Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction
- PMID: 22534499
- PMCID: PMC3458139
- DOI: 10.1016/j.psychres.2012.03.048
Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction
Abstract
We examined whether polymorphisms in the GRIK2, GRIA3 and GRIA1 genes were associated with selective serotonin reuptake inhibitor (SSRI)-associated sexual dysfunction in 114 participants treated for depression. One polymorphism in GRIA1 (rs1994862) was associated with arousal dysfunction, providing further evidence for the role of GRIA1 in mechanisms underlying SSRI-associated sexual side effects.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
References
-
- Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002a;288:1403–1409. - PubMed
-
- Bull SA, Hunkeler EM, Lee JY, Rowland CR, Williamson TE, Schwab JR, Hurt SW. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother. 2002b;36:578–584. - PubMed
-
- Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33:731–745. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources